Keyphrases
Secretin
100%
Bioactive
100%
Roux-en-Y Gastric Bypass
20%
Secretin Receptor
20%
Peptide Chemistry
20%
Disease Spectrum
20%
First-in-class
20%
Bariatric Surgery
20%
Weight Loss
20%
Therapeutic Agents
20%
SCell
10%
Clinical Problems
10%
Proteolysis
10%
Potential Treatments
10%
Comorbidity
10%
Orally Active
10%
Pancreatic Islets
10%
Peptide Analogs
10%
Length-compatible
10%
Biological Activity
10%
Metabolic Benefits
10%
Thermogenic
10%
Active Agent
10%
Agonist Efficacy
10%
New Therapeutics
10%
Gastric Acid
10%
Beneficial Effects
10%
Gut Peptides
10%
Diabetes Management
10%
Absorption Distribution
10%
Duodenum
10%
GLP-1 Receptor Agonist
10%
Insulin Secretion
10%
In Vitro Data
10%
Diabetes Incidence
10%
Minimal Length
10%
Morbid Obesity
10%
Vagal Afferents
10%
Biological Half-life
10%
Preclinical Testing
10%
Receptor Agonist
10%
Backbone Cyclization
10%
Binding Affinity
10%
Surgical Approach
10%
Focus of Attention
10%
High-affinity Binding
10%
Public Health Risk
10%
Metabolism
10%
Chemistry Techniques
10%
Vasculature
10%
Non-diabetic
10%
Stimulants
10%
Noncanonical Amino Acids
10%
Diabetes
10%
Adipocyte
10%
Satiety
10%
Miller
10%
Obesity
10%
New Drugs
10%
Increased Incidence
10%
Diagnostic Purposes
10%
Family Members
10%
Grant Applications
10%
NIH Funding
10%
Protein Conjugation
10%
Obesity Treatment
10%
Pharmacology, Toxicology and Pharmaceutical Science
Secretin
100%
Diseases
25%
Receptor Agonist
8%
Morbid Obesity
8%
Glucagon Like Peptide 1 Receptor Agonist
8%
Biological Activity
8%
Biological Half-Life
8%
Elimination
8%
Amino Acid
8%
Clinical Study
8%
Receptor
8%
Diabetes Mellitus
8%
Comorbidity
8%